Scarica l'app Stockscreener
44.64
3.31%
1.43
Dopo l'orario di chiusura:
45.53
0.89
+1.99%
Palvella Therapeutics Inc Borsa (PVLA) Ultime notizie
Will Palvella Therapeutics Inc. stock recover after recent dropMarket Volume Report & Safe Swing Trade Setups - Newser
Palvella Therapeutics Inc. stock volume spike explainedJuly 2025 Outlook & Safe Capital Preservation Plans - Newser
Palvella Therapeutics Inc. stock momentum explainedJuly 2025 Outlook & Weekly High Return Stock Opportunities - Newser
What indicators show strength in Palvella Therapeutics Inc.Weekly Trend Recap & Community Trade Idea Sharing - Newser
Is Palvella Therapeutics Inc. forming a reversal patternSwing Candidate List with Trade Cues - Newser
Is Palvella Therapeutics Inc. stock entering bullish territorySecure Buy Strategy Based on Risk Parameters - Newser
How hedge fund analytics apply to Palvella Therapeutics Inc. stockFree Stock Selection With High Accuracy - Newser
Exit strategy if you’re trapped in Palvella Therapeutics Inc.Smart Money Strategy for Growth Stocks - Newser
Palvella Therapeutics CEO to Speak at Canaccord Genuity Growth Conference - MSN
Risk vs reward if holding onto Palvella Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Palvella Therapeutics (PVLA) to Release Earnings on Thursday - Defense World
Detecting price anomalies in Palvella Therapeutics Inc. with AIFree Daily Chart Pattern Stock Forecast - Newser
What institutional flow reveals about Palvella Therapeutics Inc.Weekly Growth Portfolio Performance Summary - Newser
Palvella Therapeutics to Report Q2 Financials and Corporate Update on August 14 - MSN
Will Palvella Therapeutics Inc. price bounce be sustainableInvestment Life Cycle Planning Summary - Newser
How Palvella Therapeutics Inc. stock performs during market volatilityAsset Allocation Summary With Future Outlook - Newser
Will Palvella Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsBreakout Monitoring with Momentum Analysis - Newser
Palvella Therapeutics Inc. stock trend forecastSwing Gain Strategy with Entry Forecast - Newser
Key External Factors That Drive Palvella Therapeutics Inc. Stock Price MovementsFree Daily Chart Pattern Stock Forecast - Newser
Does Palvella Therapeutics Inc. fit your quant trading modelStock Market Trend and Pattern Analysis - Newser
Real time scanner hits for Palvella Therapeutics Inc. explainedProfitable Trading Blueprint with Entry Zones - Newser
Palvella Therapeutics to report Q2 2025 financial results on Aug 14. - AInvest
Palvella Therapeutics Q2 2025 Earnings Call Scheduled for August 14 | PVLA Stock News - Stock Titan
Analysts Set Expectations for PVLA Q2 Earnings - Defense World
How to read the order book for Palvella Therapeutics Inc.AI Trade Signal Forecast with Chart Logic - Newser
What makes Palvella Therapeutics Inc. stock price move sharplyHigh Yield Signals with Entry Timing - Newser
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Palvella Therapeutics (NASDAQ:PVLA) Rating Increased to Strong-Buy at Lifesci Capital - Defense World
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Raymond James Initiates Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $54 - 富途牛牛
Raymond James initiates Palvella Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada
Lifesci Capital Initiates Coverage on Palvella Therapeutics (NASDAQ:PVLA) - Defense World
Lifesci Capital Upgrades Palvella Therapeutics (NASDAQ:PVLA) to “Strong-Buy” - Defense World
Palvella Therapeutics CEO to Share Rare Disease Pipeline Updates at Major Growth Conference - Stock Titan
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):